STML — STEMLINE THERAPEUTICS INC

Ownership history in Stonepine Capital Management, LLC  ·  1 quarter on record

This page tracks every 13F SEC filing in which Stonepine Capital Management, LLC reported a position in STEMLINE THERAPEUTICS INC (STML). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
4.54% (2020 Q1)
Avg. % of fund
4.54%
First filed
2020 Q1
Last filed
2020 Q1
Quarters held
1
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2020 Q1 INITIATED 886,632 — — 4.54% $4.3M —
% of Fund (quarterly)

Other funds also holding STML

As of 2020 Q1 — sorted by position size

Clearline Capital LP 3Y 7Y 3.4% Rubric Capital Management LP 3Y 7Y 2.56% Bullseye Asset Management LLC 3Y 1.08% EVENTIDE ASSET MANAGEMENT, LLC 3Y 7Y 0.65% Rhenman & Partners Asset Management AB 3Y 7Y 0.44% Empire Life Investments Inc. 3Y 7Y 0.42% Schonfeld Strategic Advisors LLC 3Y 7Y 0.29% Leap Investments LP 0.27% VIRTUS ADVISERS, LLC 3Y 7Y 0.12% FARALLON CAPITAL MANAGEMENT LLC 3Y 7Y 0.1%
← Back to Stonepine Capital Management, LLC Holdings